14-day Premium Trial Subscription Try For FreeTry Free
$0.0541
-0.0045 (-7.68%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Wednesday, 24th Apr 2024 BLPH stock ended at $0.0541. This is 7.68% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 17.21% from a day low at $0.0522 to a day high of $0.0612.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Mar 19, 2024 $0.0523 $0.0570 $0.0514 $0.0524 6 940
Mar 18, 2024 $0.0481 $0.0600 $0.0481 $0.0569 6 676
Mar 15, 2024 $0.0600 $0.0600 $0.0481 $0.0500 6 764
Mar 14, 2024 $0.0570 $0.0600 $0.0470 $0.0600 54 649
Mar 13, 2024 $0.0523 $0.0523 $0.0523 $0.0523 451
Mar 12, 2024 $0.0533 $0.0566 $0.0533 $0.0534 19 932
Mar 11, 2024 $0.0533 $0.0539 $0.0533 $0.0533 18 396
Mar 08, 2024 $0.0534 $0.0562 $0.0533 $0.0539 10 514
Mar 07, 2024 $0.0533 $0.0550 $0.0533 $0.0550 108 953
Mar 06, 2024 $0.0532 $0.0532 $0.0524 $0.0527 23 157
Mar 05, 2024 $0.0515 $0.0532 $0.0515 $0.0527 11 643
Mar 04, 2024 $0.0515 $0.0532 $0.0515 $0.0515 7 296
Mar 01, 2024 $0.0515 $0.0532 $0.0515 $0.0516 38 997
Feb 29, 2024 $0.0515 $0.0515 $0.0515 $0.0515 9 663
Feb 28, 2024 $0.0515 $0.0533 $0.0510 $0.0533 82 946
Feb 27, 2024 $0.0523 $0.0523 $0.0523 $0.0523 10 367
Feb 26, 2024 $0.0525 $0.0533 $0.0510 $0.0533 165 598
Feb 23, 2024 $0.0521 $0.0524 $0.0521 $0.0521 1 601
Feb 22, 2024 $0.0519 $0.0535 $0.0519 $0.0535 112 972
Feb 21, 2024 $0.0501 $0.0549 $0.0501 $0.0535 11 927
Feb 20, 2024 $0.0501 $0.0549 $0.0501 $0.0510 10 748
Feb 16, 2024 $0.0518 $0.0549 $0.0501 $0.0549 5 556
Feb 15, 2024 $0.0501 $0.0549 $0.0501 $0.0501 9 408
Feb 14, 2024 $0.0501 $0.0549 $0.0501 $0.0501 5 894
Feb 13, 2024 $0.0501 $0.0526 $0.0501 $0.0526 5 040
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT